Diabetic modifier QTL, Dbm4, affecting elevated fasting blood glucose concentrations in congenic mice

DOI Web Site Web Site PubMed 参考文献37件
  • Takeshita Shigeru
    Department of Metabolic Diseases, Pharmacology Research Labs., Astellas Pharma Inc. Division of Genetic Information, Institute for Genome Research, The University of Tokushima
  • Kitayama Susumu
    Department of Metabolic Diseases, Pharmacology Research Labs., Astellas Pharma Inc. Division of Genetic Information, Institute for Genome Research, The University of Tokushima
  • Suzuki Takao
    Department of Functional Genomics, Molecular Medicine Research Labs., Astellas Pharma Inc. Division of Genetic Information, Institute for Genome Research, The University of Tokushima
  • Moritani Maki
    Division of Genetic Information, Institute for Genome Research, The University of Tokushima
  • Inoue Hiroshi
    Division of Genetic Information, Institute for Genome Research, The University of Tokushima
  • Itakura Mitsuo
    Division of Genetic Information, Institute for Genome Research, The University of Tokushima Setagaya Memorial Hospital

書誌事項

タイトル別名
  • Diabetic modifier QTL, <i>Dbm4</i>, affecting elevated fasting blood glucose concentrations in congenic mice

この論文をさがす

抄録

We have previously identified four significant quantitative trait loci (QTL) affecting plasma glucose concentrations on F2 progeny of hypoinsulinemic diabetic Akita mice, heterozygous for the Ins2 gene Cys96Tyr mutation, and non-diabetic A/J mice, one of which on chromosome 15 named Dbm4 (diabetic modifier QTL 4) was shown to affect fasting plasma glucose concentrations with a maximum LOD score of 6.17. To estimate the influence of Dbm4 itself to the diabetes-related phenotypes, we constructed congenic strain with heterozygous Ins2 mutation using the Akita allele as donor of Dbm4 locus in the A/J genetic background, and measured quantitative traits including plasma glucose concentrations in glucose tolerance test (GTT). In this study, we found the Akita allele in Dbm4 was associated with higher fasting plasma glucose concentrations as in previous QTL analysis. According to gene expression assay, key enzymes of hepatic gluconeogenesis were expressed to the more increased degree in the liver of congenic mice compared to the A/J allele based control mice. Based on these results, we concluded that diabetic modifier gene(s) exist on Dbm4 locus affecting fasting plasma glucose concentrations via regulation of gluconeogenic gene expression in the hypoinsulinemic diabetic condition. Identification of the modifier gene responsible for Dbm4 would provide new drug development targets for human type 2 diabetes with hepatic insulin resistance.

収録刊行物

参考文献 (37)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ